Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation.
The adult respiratory distress syndrome (ARDS) represents an acute inflammatory lung disorder, characterized by both refractory hypoxemia and a mortality rate approaching 95%. Researchers have proposed that activation of the complement (C) system may play a role in the development of the pulmonary inflammation associated with ARDS. The purpose of this investigation was to determine whether complement activation occurs to a greater extent in patients with ARDS than in patients without ARDS, thereby providing a potential mechanism for the acute inflammation seen in ARDS. In this study, we assessed plasma complement activation by measuring complement activation by-products: C1rC1s-C1 inhibitor complex and C3b-P complex, generated subsequent to activation of the classical and alternative pathways, respectively, and also the terminal complement complex, formed after activation of either the classical or alternative complement pathway. Multivariate discriminant analysis revealed that these three complement activation complexes could distinguish patients with ARDS from those without ARDS (p less than 0.04). Furthermore, these three complexes provided a more sensitive discriminator of ARDS than did plasma levels of C3a desarginine (p greater than 0.30), C5a desarginine (p greater than 0.41) and total hemolytic complement activity (CH50) (p greater than 0.72). We conclude that a temporal association exists between the complement activation and the development of ARDS. Therefore, we suggest that complement activation by-products be included in the armamentarium for ARDS.
Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Ill.
P F
PF
Langlois
M S
MS
Gawryl
J
J
Zeller
T
T
Lint
D000328:Adult; D000368:Aged; D003167:Complement Activation; D003172:Complement C1 / Q000032:analysis; D003176:Complement C3 / Q000032:analysis; D003182:Complement C5 / Q000032:analysis; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000032:analysis; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D006801:Humans; D007239:Infections / Q000150:complications; D007249:Inflammation / Q000276:immunology; D008875:Middle Aged; D012128:Respiratory Distress Syndrome / Q000150:complications / Q000276:immunology*; D014947:Wounds and Injuries / Q000150:complications
D003172:Complement C1; D003176:Complement C3; D003182:Complement C5; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins